Clinical Trials Logo

Cellulite clinical trials

View clinical trials related to Cellulite.

Filter by:

NCT ID: NCT05064761 Completed - Cellulite Clinical Trials

Safety and Effectiveness of Poly-l-lactic Acid (PLLA) for the Improvement in Appearance of Cellulite

Start date: November 19, 2021
Phase: N/A
Study type: Interventional

This pilot study has been designed to evaluate the safety and effectiveness of PLLA as a single regimen for the improvement in appearance of cellulite after changes in reconstitution procedure.

NCT ID: NCT05026216 Completed - Cellulite Clinical Trials

To Assess the Effectiveness of Multiple Dose, Multiple Concentrations of Qwo, for the Treatment of Mild to Moderate Cellulite.

Start date: March 29, 2021
Phase: Phase 4
Study type: Interventional

This is a single center, off-label, multiple dose, multiple injection areas, Phase 4 study to assess the safety and efficacy of multi-dilution CCH in adult women with mild or moderate edematous fibrosclerotic panniculopathy (EFP). 5 subjects will be screened and dosed in the buttock and thigh areas using a multi-dilution injection technique. Qualified subjects (determined by investigator assessment) will receive a single vial of 0.84 mg of CCH to treatment areas (buttocks and thighs) for a total dose of 1.68 mg in both buttocks and both thighs per treatment session × 3 treatment sessions (Day 1, Day 22, and Day 43). Subjects will have follow-up visits at approximately 90 after Day 1.

NCT ID: NCT04743635 Completed - Cellulite Clinical Trials

CONtrolled Focal Fibrous Band Release Method Study

CONFFIRM
Start date: January 7, 2021
Phase: N/A
Study type: Interventional

Study to evaluate the safety and effectiveness of the Avéli medical device to reduce the appearance of cellulite.

NCT ID: NCT04677712 Completed - Cellulite Clinical Trials

Effects of Mitigation Treatments on Bruising of CCH-aaes Treatment of Buttock Cellulite

MOBI
Start date: December 28, 2020
Phase: Phase 4
Study type: Interventional

This study will investigate treatments that may mitigate bruising after QWO™ (Collagenase clostridium histolyticum [CCH]-aaes) treatment of cellulite in the buttocks.

NCT ID: NCT04580303 Completed - Cellulite Clinical Trials

CCH Treatment of Cellulite in the Presence of Dermal Laxity With Comparison Between Two (2) Different Injection Techniques

Start date: October 1, 2020
Phase: Phase 2
Study type: Interventional

This study is designed to investigate the safety and efficacy of collagenase clostridium histolyticum (CCH) for the treatment of mild to moderate edematous fibrosclerotic panniculopathy (cellulite) in participants with moderate to severe dermal laxity in the buttocks or thighs with comparison between two (2) different CCH injection techniques.

NCT ID: NCT04498312 Completed - Cellulite Clinical Trials

Extracorporeal Shock Wave Therapy Versus Manual Lymphatic Drainageon Cellulite Post Liposuction

Start date: January 10, 2018
Phase: N/A
Study type: Interventional

To determine whether extracorporeal shock wave therapy (ESWT) or manual lymphatic drainage (MLD) is more effective for decreasing post-liposuction cellulite. Thirty females with grade 3 cellulite were randomly distributed into two equal groups: group A (ESWT group) (n=15) and group B (MLD group) (n=15). The cellulite grade was assessed by using the cellulite grading scale, and the thickness of subcutaneous fat was assessed by the skinfold caliper. The assessment was carried out before starting the treatment and after 4 weeks. All participants received treatment 2 times/ week for 4 weeks.

NCT ID: NCT04419454 Completed - Cellulite Clinical Trials

Retrospective Evaluation of Cellulite of Laxity Treatment Using Body Tite

Start date: May 5, 2020
Phase:
Study type: Observational

Retrospective Evaluation of Cellulite of Laxity Treatment Using Body Tite

NCT ID: NCT04170296 Completed - Cellulite Clinical Trials

Real World CCH Study in Adult Females With Cellulite

Start date: November 1, 2019
Phase: Phase 3
Study type: Interventional

This is a multicenter, open-label, multiple dose, 2 cohort, Phase 3b study to assess the safety and efficacy of CCH in adult women with mild or moderate edematous fibrosclerotic panniculopathy (EFP). Cohort 1 will include approximately 80 subjects with mild or moderate EFP in the posterolateral thighs and Cohort 2 will include approximately 70 subjects with mild or moderate EFP in the buttocks.

NCT ID: NCT04065711 Completed - Cellulite Clinical Trials

Study of the Soliton Rapid Acoustic Pulse (RAP) Device for the Treatment of Cellulite

Start date: July 20, 2019
Phase: N/A
Study type: Interventional

To evaluate the safety, and efficacy of Soliton's Rapid Acoustic Pulse (RAP) device for the temporary improvement in the appearance of cellulite.

NCT ID: NCT03981198 Completed - Cellulite Clinical Trials

Proof of Concept (POC) Study of the Soliton Rapid Acoustic (RAP) for the Treatment of Cellulite

Start date: July 31, 2018
Phase: N/A
Study type: Interventional

Feasibility study is to evaluate the safety, tolerability and efficacy of Soliton's Rapid Acoustic Pulse (RAP) device for the treatment of cellulite